Angiotensin III: A physiological relevant peptide of the renin angiotensin system

被引:66
作者
Yugandhar, Vudhya G. [1 ]
Clark, Michelle A. [1 ]
机构
[1] Nova SE Univ, Coll Pharm, Dept Pharmaceut Sci, Ft Lauderdale, FL 33328 USA
关键词
Angiotensin; Aminopeptidase A; Blood pressure; Cardiovascular; Renin angiotensin system; Sodium appetite; Vasopressin; AMINOPEPTIDASE-A INHIBITORS; PARAVENTRICULAR NUCLEUS; BLOOD-PRESSURE; VASOPRESSIN RELEASE; DOUBLE BLOCKADE; BRAIN; RAT; HYPERTENSION; RECEPTORS; AMASTATIN;
D O I
10.1016/j.peptides.2013.04.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The renin angiotensin system (RAS) is a peptide hormone system that plays an important role in the pathophysiology of various diseases, including congestive heart failure, hypertension, myocardial infarction, and diabetic nephropathy. This has led researchers to focus extensively on this system, leading to the discovery of various peptides, peptidases, receptors and signal transduction mechanisms intrinsic to the RAS. Angiotensinogen (AGT), angiotensin (Ang) II, Ang III, Ang IV, and Ang-(1-7) are the main biologically active peptides of RAS. However, most of the available studies have focused on Ang II as the likely key peptide from the RAS that directly and indirectly regulates physiological functions leading to pathological conditions. However, data from recent studies suggest that Ang III may produce physiologically relevant effects that are similar to those produced by Ang II. Hence, this review focuses on Ang III and the myriad of physiological effects that it produces in the body. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:26 / 32
页数:7
相关论文
共 80 条
[1]  
ABHOLD RH, 1987, J PHARMACOL EXP THER, V242, P957
[2]   The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition [J].
Atlas, Steven A. .
JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (08) :S9-S20
[3]   INCREASED SODIUM APPETITE IN THE RAT INDUCED BY INTRA-CRANICAL ADMINISTRATION OF COMPONENTS OF THE RENIN-ANGIOTENSIN SYSTEM [J].
AVRITH, DB ;
FITZSIMONS, JT .
JOURNAL OF PHYSIOLOGY-LONDON, 1980, 301 (APR) :349-364
[4]   Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine [J].
Banegas, I ;
Prieto, I ;
Vives, F ;
Alba, F ;
Duran, R ;
Segarra, AB ;
de Gasparo, M ;
Ramírez, M .
NEUROENDOCRINOLOGY, 2004, 80 (04) :219-224
[5]   Brain aminopeptidases and hypertension [J].
Banegas, Inmaculada ;
Prieto, Isabel ;
Vives, Francisco ;
Alba, Francisco ;
de Gasparo, Marc ;
Segarra, Ana Belen ;
Hermoso, Francisco ;
Duran, Raquel ;
Ramirez, Manuel .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2006, 7 (03) :129-134
[6]   PRESSOR-RESPONSES TO AMASTATIN, BESTATIN AND PLUMMER INHIBITORS ARE SUPPRESSED BY PRETREATMENT WITH THE ANGIOTENSIN RECEPTOR ANTAGONIST SARTHRAN [J].
BATT, CM ;
KLEIN, EW ;
HARDING, JW ;
WRIGHT, JW .
BRAIN RESEARCH BULLETIN, 1988, 21 (05) :731-735
[7]   Possible contribution of brain angiotensin III to ingestive behaviors in baboons [J].
Blair-West, JR ;
Carey, KD ;
Denton, DA ;
Madden, LJ ;
Weisinger, RS ;
Shade, RE .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2001, 281 (05) :R1633-R1636
[8]   EFFECT OF HEPTAPEPTIDE (2-8) AND HEXAPEPTIDE (3-8) FRAGMENTS OF ANGIOTENSIN-II ON ALDOSTERONE SECRETION [J].
BLAIRWES.JR ;
COGHLAN, JP ;
DENTON, DA ;
FUNDER, JW ;
SCOGGINS, BA ;
WRIGHT, RD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 32 (04) :575-+
[9]   A DOSE-RESPONSE COMPARISON OF THE ACTIONS OF ANGIOTENSIN-II AND ANGIOTENSIN-III IN SHEEP [J].
BLAIRWEST, JR ;
COGHLAN, JP ;
DENTON, DA ;
FEI, DTW ;
HARDY, KJ ;
SCOGGINS, BA ;
WRIGHT, RD .
JOURNAL OF ENDOCRINOLOGY, 1980, 87 (03) :409-417
[10]   ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain [J].
Blume, A ;
Undeutsch, C ;
Zhao, Y ;
Kaschina, E ;
Culman, J ;
Unger, T .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2005, 289 (03) :R845-R850